INFLORAN 20CPS 0.25G

INFLORAN RIGID CAPSULES

active ingredients

One capsule contains: Active Ingredients: – Bifidobacterium bifidum vivo liofilizzato no less than 1,000 million – Lactobacillus acidophilus vivo liophilisizzato no less than 1,000 million excipients with known effects: sucrose, lactose monohydrate. For the full list of excipients, see paragraph 6.1.

Excellent

Saccarosium, sodium citrate, magnesium stearate, potassium dibasic phosphate, lactose monohydrate excipients of the Gelatin envelope, titanium dioxide (E171), erythrosine (E127), indigotin (E132), chinoline yellow (E104).

Therapeutic indications

Protrude. Prevention of gastrointestinal dysmicrobial syndromes. Therapy. Diarrhoic and dispeptic syndromes from altered bacterial flora (diarrhea, aspecific enteritis of adults and infants, colitis). Dismicrobial antibiotics. Digestive disorders in artificially nourished milking. Adjuvant in the elimination of pathogenic enterobacteria resistant to chemoantibiotics.

Contraindications

Hypersensitivity to active ingredients or any of the excipients listed in paragraph 6.1.

Population

Population One capsule three times a day Mode of administration: To swallow with some non-hot liquid both in the child and in the adult, before meals. Pediatric population In milkers pour the contents of the capsule into a little liquid or sugary water, not hot. Do not exceed the recommended doses.

Conservation

Store in the refrigerator (2°C – 8°C). Store in the original packaging to protect the medicine from light.

Warnings

Do not use for protracted treatments. After a short period of treatment without appreciable results consult your doctor. You can see color differences between a lot and the other, due to the excipients of the preparation. The medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, lactase deficiency, or glucose–galactose mal absorption, should not take this medicine. The medicinal product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose–galactose mal absorption, or isomaltase sucrasis failure, should not take this medicine.

Interactions

Don't report.

Effects

Suggested doses are not reported side effects. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at: http://www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

No overdose reactions have been reported.

Infloran can be administered during pregnancy and nursing.

Source: Farmadati